After detection, it was found that RIMS3 was significantly increased in normal samples, while SLC16A8 was substantially upregulated in tumor samples (Figures 6(a) and 6(d)), which indicated that RIMS3 was a suppressor gene while SLC16A8 was an oncogene in CRC. This evidence concerns the gene SLC16A8 and colorectal carcinoma.